Patient Guide: Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 191 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04179175
Status: ACTIVE_NOT_RECRUITING
Condition: Hidradenitis Suppurativa
Phase: PHASE3

Where You Can Participate

This study is available at 191 locations across the country.

Top locations include:
  • • Rogers, Arkansas
  • • San Diego, California
  • • San Diego, California
  • • And 188 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa - Join Clinical Trial NCTNCT04179175

How to Join This Clinical Trial - NCTNCT04179175

Learn how to participate in this PHASE3 trial studying an investigational therapy for Hidradenitis Suppurativa. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hidradenitis Suppurativa. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hidradenitis Suppurativa
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04179175 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 191 locations. Find a study site near you:

Clinical Research Site

Rogers, Arkansas 72758 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92123 - United States

Status: Contact for availability

Clinical Research Site

Whittier, California 92677 - United States

Status: Contact for availability

Clinical Research Site

Coral Gables, Florida 33134 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33125 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33609 - United States

Status: Contact for availability

Clinical Research Site

Tampa, Florida 33612 - United States

Status: Contact for availability

Clinical Research Site

Sandy Springs, Georgia 30328 - United States

Status: Contact for availability

Clinical Research Site

Glenview, Illinois 60077 - United States

Status: Contact for availability

And 181 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Hidradenitis Suppurativa:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships